Carl Zeiss Meditec has announced better than expected results for the quarter ended March 31 (Q2) as sales jumped by 19 percent year-on-year to €560 million based on preliminary data. The strong growth was driven by Dutch Ophthalmic Research Center (DORC), a business acquired last year and integrated from April ...
Buying a membership today will give you:
To continue reading this article register now.